Quess Corp, India’s leading business services provider, announced the launch of its new healthcare vertical to address the shortage of healthcare professionals.
The vertical aims to provide trained healthcare manpower, home care solutions, and end-to-end hospital management services by identifying, training & upskilling healthcare professionals through a network of accredited medical training institutes, enabling quick & on-demand deployment.
Quess Corp has signed an MoU with the Association of Healthcare Providers (India) (AHPI), a not-for-profit representative body of healthcare providers, to evangelize formalization of training and staffing services for healthcare professionals and create a talent marketplace for private and public healthcare institutions.
The collaboration aspires to create a pipeline of trained paramedical and healthcare service professionals through a proposed hire-train-deploy model, besides building a digital pool of highly skilled, experienced, ready-to-hire doctors across India.
In addition to creating an organized demand and supply support service for healthcare manpower such as nurses, paramedics, doctors, phlebotomists, and lab technicians, the collaboration will also enable corporates to set up safer workspaces with adequate medical facilities, and to train candidates with endorsements from reputed domestic and international accreditations. Through this alliance, Quess Corp and AHPI plan to jointly work towards industry advocacy in critical areas of staffing and healthcare manpower management.
Dr Naresh Shetty, president, Quess Healthcare said, “In India, the healthcare segment faces dismaying challenges with an acute shortage of skilled manpower to the tune of six million paramedics today. We hope to bridge this gap and indisputably impact skill development and knowledge enhancement of the healthcare sector, which is the absolute need of the hour. Through tech-enabled skilling and access to a talent pool of trained professionals, we want to empower healthcare providers to cater to a wide public reach while providing access to quality healthcare for all.”
Dr Giridhar Gyani, director general, AHPI said “Improving the Indian healthcare system by expanding basic healthcare access to the larger community has been our long-standing commitment at AHPI. We are pleased to partner with Quess Corporation, the leading manpower service company, and believe that together, we can successfully redesign and advocate for the medical ecosystem with trained and qualified workforce.”
Why will CM be the next generation on quality?
The Fifth International Conference on Chemicals Management (ICCM5) concluded on 30 September in Bonn, Germany, by adopting “a comprehensive global framework that sets concrete targets and guidelines for key sectors across the entire lifecycle of chemicals”.
In October, the People’s Republic of China celebrates its annual national holiday, known as Golden Week. Similar to Chinese New Year, the entire country is on holiday, resulting in business closures and a potential 14-day halt in production and transportation of manufactured goods.
The European Chemicals Agency (ECHA) has amended the Prior Informed Consent (PIC) Regulation, EU 64/2012, to add 27 pesticides and eight industrial chemicals into Annex I, bringing the total to 295. As a result, EU exporters are now required to notify their intentions to export them from 1 November onwards.
The global custom synthesis and manufacturing market was valued at US$271.33 billion in 2022. The market value is expected to reach US$474.94 billion by 2028.
The ocean freight industry is undergoing a massive transformation, as the technology and supply chain management tools are being improved by the day, impacting ocean freight rates.
In the second half of 2022, China unveiled the details of its data export regulations, providing further explanations to its existing laws and regulations on data.
The current energy crisis has reached an unsustainable level for the European chemical industry. For the first time ever, the EU imports more chemicals than it exports, both in volume and value, resulting in a trade deficit of € 5.6 bn for the first half of 2022.
Endocrine Disrupting Chemicals (also referred to as hormone disruptors or EDCs) are synthetic chemicals that are not produced by the human body and that disrupt the normal functioning of humans and animals.